Proteor welcomes Eurazeo – through its Nov Santé Actions Non Cotées fund – and Crédit Mutuel Equity to its capital, alongside Bpifrance and BNP Paribas Développement, which is reinvesting in the transaction, as Ardian, a minority shareholder since 2021, exits.
A recognized player in the orthopedics market, the family-owned company led by Edouard Archambeaud (4th generation of the Pierron family) has a turnover of nearly €170 million and employs 1,100 people. Majority-owned by the founding family group, Proteor aims to accelerate its development in France andinternationally, while preserving its independence and remaining faithful to its mission of improving patient autonomy and quality of life.
Click here to read more.